The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Open accessAbstract
Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli. They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics. Herein, we demonstrate that small-molecule IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of auto-ubiquitination activity and rapid proteasomal degradation of c-IAPs. The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis. Additionally, the c-IAP proteins were found to function as regulators of NF-kappaB signaling. Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degradation of NIK, the central ser/thr kinase in the noncanonical NF-kappaB pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This switch between target substrate ubiquitylation and autoubiquitylation following changes in binding partner might be a general feature of RING E3 ligases, since ligand binding to IAP (a member of the RING E3 inhibitor of apoptosis proteins) stimulates IAP auto-destruction [43].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [43]
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., HAVEMAN, J., & Chris van, B. R. E. E. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,202
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I. I., Oliver, H., Lutter, M. L., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,577
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,469
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
TNF-R1 Signaling: A Beautiful Pathway
Chen, G., & Goeddel, D. V. (2002) · Science · doi:10.1126/science.1071924 · Cited by 1,930
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,000
Friboulet, L., Gourzonès, C., Tsao, S. W., Morel, Y., Paturel, C., Temam, S., Uzan, C., & Busson, P. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-327 · Cited by 25
Schirmer, M., Trentin, L., Queudeville, M., Seyfried, F., Demir, S., Tausch, E., Stilgenbauer, S., Eckhoff, S. M., Meyer, L. H., & Debatin, K. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.382 · Cited by 26
Weinelt, N., Karathanasis, C., Smith, S. M., Medler, J., Malkusch, S., Fulda, S., Wajant, H., Heilemann, M., & van Wijk, S. J. L. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ab0420-572rr · Cited by 25
Cytoplasmic and Nuclear Functions of cIAP1
Zadoroznyj, A., & Dubrez, L. (2022) · Biomolecules · doi:10.3390/biom12020322 · Cited by 28
Raulf, N., El-Attar, R. H., Kulms, D., Lecis, D., Delia, D., Walczak, H., Papenfuss, K., Odell, E. W., & Tavassoli, M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.521 · Cited by 27
Tan, B. M., Zammit, N. W., Yam, A. O. W., Slattery, R. M., Walters, S. N., Malle, E. K., & Grey, S. T. (2012) · Diabetologia · doi:10.1007/s00125-012-2784-x · Cited by 25
“Birc2 mouse embryonic fibroblasts cells (MEFs) and Birc2Birc3 cancer cells accumulate high NIK levels, and NIK in turn phosphorylates IκB kinase (IKK)α, inducing activation of the non-canonical NF-κB pathway [39, 40].”
BackgroundZhang, S., Li, G., Zhao, Y., Liu, G., Wang, Y., Ma, X.-X., Li, D., Wu, Y., & Lü, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051461 · Cited by 25
Smac Mimetic Compounds Potentiate Interleukin-1β-mediated Cell Death
Cheung, H. H., Beug, S. T., Jean, M. S., Brewster, A., Kelly, N. L., Wang, S., & Korneluk, R. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183616 · Cited by 25
Development of a peptide-based inducer of nuclear receptors degradation
Demizu, Y., Ohoka, N., Nagakubo, T., Yamashita, H., Misawa, T., Okuhira, K., Naito, M., & Kurihara, M. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.013 · Cited by 25
Inhibition of cIAP1 as a strategy for targeting c-MYC–driven oncogenic activity
Li, H., Fang, Y., Niu, C., Cao, H., Mi, T., Zhu, H., Yuan, J., & Zhu, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807711115 · Cited by 25
“Since Smac mimetics are known to promote the E3 ubiquitin ligase activity of cIAP1 (4, 5), we next characterized the effect of D19 on ubiquitination of cIAP1 with Smac.”
Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy
Mauceri, H. J., Beckett, M. A., Liang, H. L., Sutton, H. G., Pitroda, S. P., Galka, E., Efimova, E. V., Darga, T. E., Khodarev, N. N., King, C. R., et al. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.86 · Cited by 25
Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy
Knoll, G., Bittner, S., Kurz, M., Jantsch, J., & Ehrenschwender, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9206 · Cited by 25
“SMAC mimetics do not exhibit an exclusive specificity for a single IAP protein and target to a varying degree cIAP1, cIAP2 and XIAP [41].”
BackgroundCampbell, G. R., Zhuang, J., Zhang, G., Landa, I., Kubiatowicz, L. J., Dehaini, D., Fang, R. H., Zhang, L., & Spector, S. A. (2021) · Theranostics · doi:10.7150/thno.59728 · Cited by 24
SMAC Mimetics as Therapeutic Agents in HIV Infection
Molyer, B., Kumar, A., & Angel, J. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.780400 · Cited by 24
A Toolbox for the Generation of Chemical Probes for Baculovirus IAP Repeat Containing Proteins
Schwalm, M. P., Berger, L. M., Meuter, M. N., Vasta, J. D., Corona, C. R., Röhm, S., Berger, B., Farges, F., Beinert, S. M., Preuß, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.886537 · Cited by 21
“BIRC2/3 E3 ligases are involved in the modulation of diverse pathways including TNFα regulation through TRAF2 degradation and the regulation of the NFκB pathway (Varfolomeev et al., 2007; Vince et al., 2007).”
BackgroundInfluentialDeubiquitinases in cell death and inflammation
Newton, K., & Gitlin, A. D. (2022) · Biochemical Journal · doi:10.1042/bcj20210735 · Cited by 26
cIAPs control RIPK1 kinase activity‐dependent and ‐independent cell death and tissue inflammation
Schorn, F., Werthenbach, J. P., Hoffmann, M., Daoud, M., Stachelscheid, J., Schiffmann, L. M., Hildebrandt, X., Lyu, S. I., Peltzer, N., Quaas, A., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2023113614 · Cited by 24
“Ubiquitylated cIAPs then undergo rapid proteasomal degradation which, in turn, causes NIK accumulation on the one hand and RIPK1 kinase activity-dependent TNF-induced cell death on the other hand (Varfolomeev et al , 2007; Vince et al , 2007).”
BackgroundMiddleton, A. J., Budhidarmo, R., & Day, C. L. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801430-1.00010-x · Cited by 24
Control of NF-κB Activity by Proteolysis
Baud, V., & Derudder, E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_101 · Cited by 24
Seidelin, J. B. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2016.1101245 · Cited by 24
“It should be remembered that cIAP2 expression is itself regulated by autoubiquitination via the RING finger domain and that inhibition of the proteasome complex thus could affect the cIAP2 expression without NF-kB involvement.[177,178] If this was the case, then MG-132 coincubation would be expected to increase the ex…”
Philip, L., & Shivakumar, K. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.06.009 · Cited by 24
“The pro-survival role of cIAP-2 under oxidative stress observed in our study may be particularly important since oxidative stress is reported to increase TNF-α production [29], which in turn can induce apoptosis by the extrinsic pathway that is inhibited by cIAP-2 [30].”
BackgroundTristetraprolin controls the stability of cIAP2 mRNA through binding to the 3′UTR of cIAP2 mRNA
Kim, C. W., Kim, H. K., Vo, M., Lee, H. H., Kim, H. J., Min, Y. J., Cho, W. J., & Park, J. W. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.136 · Cited by 24
Ritchie, S. A., Jayasinghe, D., Davies, G. F., Ahiahonu, P. W. K., Ma, H., & Goodenowe, D. B. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-59 · Cited by 24
H. pylori infection confers resistance to apoptosis via Brd4-dependent BIRC3 eRNA synthesis
Chen, Y., Sheppard, D., Dong, X., Hu, X., Chen, M., Chen, R., Chakrabarti, J. L., Zavros, Y. L., Peek, R. M., & Chen, L. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02894-z · Cited by 24
Mak, P. Y., Mak, D. H. F., Ruvolo, V. R., Jacamo, R. O., Kornblau, S. M., Kantarjian, H. M., Andreeff, M., & Carter, B. Z. (2014) · British Journal of Haematology · doi:10.1111/bjh.13054 · Cited by 23
Hussain, M., Zimmermann, V., van Wijk, S. J. L., & Fulda, S. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.025 · Cited by 22
Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities in vitro
Singh, S., Ng, J., Nayak, D., & Sivaraman, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010327 · Cited by 23
“The IAP family is, in turn, regulated by a class of inhibitor proteins known as IAP antagonists, which induce apoptosis through both caspase-dependent and -independent mechanisms (16).”
BackgroundDhuria, S. V., Einolf, H. J., Mangold, J. B., Sen, S., Gu, H., Wang, L., & Cameron, S. B. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.79 · Cited by 23
cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation
Marivin, A., Berthelet, J., Cartier, J., Paul, C., Gemble, S., Morizot, A., Boireau, W., Saleh, M., Bertoglio, J. H., Solary, É., et al. (2013) · Oncogene · doi:10.1038/onc.2013.499 · Cited by 23
Sun, Q., Zheng, X., Zhang, L., & Yu, J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2262 · Cited by 23
“In some cancer cells, Smac mimetics alone promote apoptosis by engaging TNF-α signaling through IAP degradation (23-26).”
Haß, C., Belz, K., Schoeneberger, H., & Fulda, S. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.01.004 · Cited by 23
Mohideen, F., Paulo, J. A., Ordureau, A., Gygi, S. P., & Harper, J. W. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m117.068189 · Cited by 23
Busca, A., Konarski, Y., Gajanayaka, N., O’Hara, S., Angel, J. B., Kozlowski, M., & Kumar, A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700199 · Cited by 28
Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Skeldon, A. M., Morizot, A., & Saleh, M. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.46 · Cited by 24
The kinase NIK as a therapeutic target in multiple myeloma
Gardam, S., & Beyaert, R. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.548861 · Cited by 23
Crawford, N., Salvucci, M., Hellwig, C. T., Lincoln, F. A., Mooney, R. E., O’Connor, C. L., Prehn, J. H., Longley, D. B., & Rehm, M. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0082-y · Cited by 22
“…initial rapid degradation induced by IAP antagonists; this is because cIAP1 acts as an E3 ligase for cIAP2 and degradation of cIAP1/2 leads to activation of the non-canonical NF κ B pathway resulting in increased expression of NF κ B-driven genes, including BIRC3, the gene encoding cIAP2 (13,14).”
Dittmann, J., Haydn, T., Metzger, P., Ward, G. A., Boerries, M., Vogler, M., & Fulda, S. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0465-8 · Cited by 24
Abaza, A., Vasavada, A. M., Sadhu, A., Valencia, C., Fatima, H., Nwankwo, I., Anam, M., Maharjan, S., Amjad, Z., & Khan, S. (2022) · Cureus · doi:10.7759/cureus.28496 · Cited by 23
“Furthermore, c-IAP1 and c-IAP2 are important organizers to control the nuclear factor kappa b (NF-κB) pathway and boost carcinogenesis by catalyzing NF-κB inducing kinase (NIK) breakdown [54].”
BackgroundHoefsmit, E. P., van Royen, P. T., Rao, D., Stunnenberg, J. A., Dimitriadis, P., Lieftink, C., Morris, B., Rozeman, E. A., Reijers, I. L. M., Lacroix, R., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0494 · Cited by 23
cIAP2 represses IKKα/β-mediated activation of MDM2 to prevent p53 degradation
Lau, R., Niu, M. Y., & Pratt, M. A. C. (2012) · Cell Cycle · doi:10.4161/cc.22223 · Cited by 22
Marschall, V., & Fulda, S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.235 · Cited by 22
IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα
Shekhar, T. M., Miles, M. A., Gupte, A., Taylor, S., Tascone, B., Walkley, C. R., & Hawkins, C. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8980 · Cited by 22
Roles of c-IAP Proteins in TNF Receptor Family Activation of NF-κB Signaling
Varfolomeev, E. E., Goncharov, T., & Vucic, D. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2422-6_15 · Cited by 21
Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis
Welsh, K., Milutinovic, S., Ardecky, R., González‐López, M., Reddy, S., Teriete, P., Finlay, D., Riedl, S. J., Matsuzawa, S., Pinilla, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161952 · Cited by 26
Oberoi‐Khanuja, T. K., & Rajalingam, K. (2012) · Small GTPases · doi:10.4161/sgtp.19988 · Cited by 22
Feltham, R., Khan, N. R., & Silke, J. (2012) · IUBMB Life · doi:10.1002/iub.565 · Cited by 22
“Furthermore the importance of cIAPs in promoting the generation of different types of ubiquitin chains has now also been demonstrated on RIPK1 in cells, treated with smacmimetics or otherwise deficient in cIAPs, following TNF stimulation (23, 56–60) RIP kinases may be general substrates of IAPs because ubiquitylation…”
BackgroundInfluentialAn apoptosis-independent role of SMAC in tumor suppression
Qiu, W., Liu, H., Sebastini, A., Sun, Q., Wang, H., Zhang, L., & Yu, J. (2012) · Oncogene · doi:10.1038/onc.2012.265 · Cited by 22
Redd, P. S., Lu, C., Klement, J. D., Ibrahim, M. L., Zhou, G., Kumai, T., Celis, E., & Liu, K. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1483302 · Cited by 21
Shawgo, M. E., Shelton, S. N., & Robertson, J. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032359 · Cited by 21
Soubéran, A., Cappaï, J., Chocry, M., Nuccio, C., Raujol, J., Colin, C., Lafitte, D., Kovacic, H., Quillien, V., Baeza, N., et al. (2019) · Stem Cells · doi:10.1002/stem.2997 · Cited by 21
Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis
LingHu, H.-R., Luo, H., & Lin, G. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s242567 · Cited by 23
Yin, Y., Sheng, L., Zhang, J., Zhang, L., Liu, J., Wen, X., Liu, Y., Si, Y., & Cheng, K. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105865 · Cited by 21
Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death
Liu, L., Sandow, J. J., Pedrioli, D. M. L., Samson, A. L., Silke, N., Kratina, T., Ambrose, R. L., Doerflinger, M., Hu, Z., Morrish, E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh2332 · Cited by 24
Ferris, R. L., Harrington, K. J., Schoenfeld, J. D., Tahara, M., Esdar, C., Salmio, S., Schröeder, A., & Bourhis, J. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102492 · Cited by 22
Salako, M. A., Kulbe, H., Ingemarsdotter, C. K., Pirlo, K. J., Williams, S. L., Lockley, M., Balkwill, F. R., & McNeish, I. A. (2010) · Molecular Therapy · doi:10.1038/mt.2010.247 · Cited by 21
Protease Activity of the API2–MALT1 Fusion Oncoprotein in MALT Lymphoma Development and Treatment
Rosebeck, S., Lucas, P. C., & McAllister‐Lucas, L. M. (2011) · Future Oncology · doi:10.2217/fon.11.35 · Cited by 21
“In the absence of noncanonical NF-kB-activating stimuli, such as lymphotoxin-b and B-cell activating factor belonging to the TNF family (BAFF), NIK protein is maintained at low levels owing to its association with a complex of proteins, including TNF receptor-associated factors (TRAFs)2 and 3, cIAP1 and cIAP2 (API2),…”
BackgroundVu, N., Park, M. A., Shultz, M. D., Bulut, G. B., Ladd, A. C., & Chalfant, C. E. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2512 · Cited by 21
“Also of note, several groups have detailed a role for cIAP1 in an autocrine-feedbackmechanism involving TNFa, which is induced by the treatment of cells with Smac mimetics known to bind the BIR3 domain of cIAP1 (35, 39).”
Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant
Richmond, J., Robbins, A. K., Evans, K., Beck, D., Kurmasheva, R. T., Billups, C. A., Carol, H., Heatley, S. L., Sutton, R., Marshall, G. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0523 · Cited by 26
“PDXs and primary cells remains unclear and may be due to autocrine production; perhaps stimulated by birinapant treatment itself (40,41,48).”
TRAF2 Controls Death Receptor-Induced Caspase-8 Processing and Facilitates Proinflammatory Signaling
Kreckel, J., Anany, M. A., Siegmund, D., & Wajant, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02024 · Cited by 22
Jinesh, G. G., Laing, N. M., & Kamat, A. M. (2015) · Biochemical Journal · doi:10.1042/bj20150877 · Cited by 20
Liu, Y., Gokhale, S., Jung, J., Zhu, S., Luo, C., Saha, D., Guo, J. Y., Zhang, H., Kyin, S., Zong, W., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.670338 · Cited by 20
Current strategies to induce selective killing of HIV-1-infected cells
Campbell, G. R., & Spector, S. A. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0422-636r · Cited by 19
Jiang, Y., Ni, S., Xiao, B., & Jia, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.019 · Cited by 22
“The IAP family, which consists of cIAP1/2 (cellular inhibitor of apoptosis) and XIAP (X-linked inhibitor of apoptosis), induces apoptosis by various mechanisms, including receptor-mediated, mitochondria-medi-ated, and TNF factor receptor 1 (TNFR1)-mediated apo-tosis 310,311 .”
BackgroundFn14 and TNFR2 as regulators of cytotoxic TNFR1 signaling
Siegmund, D., Zaitseva, O., & Wajant, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1267837 · Cited by 20
Langdon, C. G., Wiedemann, N., Held, M. A., Mamillapalli, R., Iyidogan, P., Theodosakis, N., Platt, J. T., Lévy, F., Vuagniaux, G., Wang, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6138 · Cited by 20
Rettinger, E., Glatthaar, A., Abhari, B. A., Oelsner, S., Pfirrmann, V., Huenecke, S., Kuçi, S., Kreyenberg, H., Willasch, A. M., Klingebiel, T. E., et al. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00075 · Cited by 21
Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia
Fulda, S. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07603.x · Cited by 20
“…complex with XIAP BIR3, Smac mimetics were designed, which bind to one or several of the BIR domains of IAP family proteins (Li et al, 2004; Sun et al, 2004a,b, 2006; Bockbrader et al, 2005; Zobel et al, 2006; Gaither et al, 2007; Petersen et al, 2007; Varfolomeev et al, 2007; Vince et al, 2007).”
Two distinct signalling cascades target the NF-κB regulatory factor c-IAP1 for degradation
Csomos, R. A., Wright, C. W., Galbán, S., Oetjen, K. A., & Duckett, C. S. (2009) · Biochemical Journal · doi:10.1042/bj20082140 · Cited by 20
Roesler, S., Eckhardt, I., Wolf, S., & Fulda, S. (2016) · Oncotarget · doi:10.18632/oncotarget.6915 · Cited by 21
Characterization of ML-IAP protein stability and physiological role in vivo
Varfolomeev, E. E., Moradi, E., Dynek, J. N., Zha, J., Fedorova, A. V., Deshayes, K., Fairbrother, W. J., Newton, K., LeCouter, J. E., & Vucic, D. (2012) · Biochemical Journal · doi:10.1042/bj20121103 · Cited by 20
Structure and Function of Tumor Necrosis Factor (TNF) at the Cell Surface
Wu, H., & Hymowitz, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00040-1 · Cited by 25
Najem, S., Langemann, D., Appl, B., Trochimiuk, M., Hundsdoerfer, P., Reinshagen, K., & Eschenburg, G. (2016) · Oncotarget · doi:10.18632/oncotarget.12055 · Cited by 20
SMAC mimetics promote NIK-dependent inhibition of CD4 + T H 17 cell differentiation
Rizk, J., Kaplinsky, J., Agerholm, R., Kadekar, D., Ivars, F., Agace, W. W., Wong, W. W.-L., Szucs, M. J., Myers, S. A., Carr, S. A., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aaw3469 · Cited by 20
Feoktistova, M., Makarov, R., Brenji, S., Schneider, A. T., Hooiveld, G. J. E. J., Luedde, T., Leverkus, M., Yazdi, A. S., & Panayotova‐Dimitrova, D. (2020) · Cells · doi:10.3390/cells9020351 · Cited by 19
cIAP-1 Controls Innate Immunity to C. pneumoniae Pulmonary Infection
Prakash, H., Becker, D., Böhme, L., Albert, L., Witzenrath, M., Rosseau, S., Meyer, T. F., & Rudel, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006519 · Cited by 20
Lee, S. H., Lee, J.-Y., Jung, C. L., Bae, I., Suh, K. H., Ahn, Y., Jin, D.-H., Kim, T. W., Suh, Y.-A., & Jang, S. J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.447 · Cited by 20
Discovery of aminopiperidine-based Smac mimetics as IAP antagonists
Hennessy, E. J., Saeh, J. C., Li, S., Macintyre, T., Wang, H., Larsen, N., Aquila, B. M., Ferguson, A. D., Laing, N. M., & Omer, C. A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.109 · Cited by 20
Antagonists of inhibitor of apoptosis proteins based on thiazole amide isosteres
Cohen, F., Koehler, M. F. T., Bergeron, P., Elliott, L. O., Flygare, J. A., Franklin, M. C., Gazzard, L. J., Keteltas, S. F., Lau, K., Ly, C. Q., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.021 · Cited by 20
Internal motions prime cIAP1 for rapid activation
Phillips, A. H., Schoeffler, A. J., Matsui, T., Weiss, T. M., Blankenship, J. W., Zobel, K., Giannetti, A. M., Dueber, E. C., & Fairbrother, W. J. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2916 · Cited by 21
A Generic Platform for Cellular Screening Against Ubiquitin Ligases
Maculins, T., Carter, N., Dorval, T., Hudson, K., Nissink, J. W. M., Hay, R. T., & Alwan, H. A. J. (2016) · Scientific Reports · doi:10.1038/srep18940 · Cited by 19
Hyder, U., McCann, J. L., Wang, J., Fung, V., Bayo, J., & D’Orso, I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004470117 · Cited by 19
den Besten, W., Verma, K., Yamazoe, S., Blaquière, N., Phung, W., Izrael-Tomasevic, A., Mulvihill, M. M., Helgason, E., Prakash, S., Goncharov, T., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05269 · Cited by 20
The expanding role of IAP antagonists for the treatment of head and neck cancer
Kansal, V., Kinney, B. L. C., Uppada, S. B., Saba, N. F., Stokes, W. A., Buchwald, Z. S., & Schmitt, N. C. (2023) · Cancer Medicine · doi:10.1002/cam4.6011 · Cited by 19
Drug Resistance and Molecular Cancer Therapy: Apoptosis Versus Autophagy
Trowman, R., Bryan, W., Nicholas, F., & Xu, L. (2013) · InTech eBooks · doi:10.5772/55415 · Cited by 20
An introduction to molecular targeted therapy of cancer
Allgayer, H., & Fulda, S. (2008) · Advances in Medical Sciences · doi:10.2478/v10039-008-0025-9 · Cited by 20
Interplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the Host
Cieniewicz, B., Santana, A. L., Minkah, N. K., & Krug, L. T. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01202 · Cited by 18
“…cells, NF-κB-inducing kinase (NIK), which is the major IKKα-activating kinase in cells, is constitutively active, but is present at very low levels due to its constitutive degradation by cIAP1/2 (Varfolomeev et al., 2007), dependent on TRAF3 and TRAF2 (Liao et al., 2004; Gardam et al., 2008).”
Dizdar, L., Oesterwind, K. A., Riemer, J. C., Werner, T. A., Mersch, S., Möhlendick, B., Schütte, S. C., Verde, P. E., Raba, K., Topp, S. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14207 · Cited by 19
Lacher, S. M., Thurm, C., Distler, U., Mohebiany, A. N., Israel, N., Kitic, M., Ebering, A., Tang, Y., Klein, M., Wabnitz, G. H., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.017 · Cited by 19
Gokhale, S., Lu, W., Zhu, S., Liu, Y., Hart, R. P., Rabinowitz, J. D., & Xie, P. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900658 · Cited by 19
Apoptotic sensitivity of murine IAP-deficient cells
Rumble, J. M., Bertrand, M. J. M., Csomos, R. A., Wright, C. W., Albert, L., Mak, T. W., Barker, P. A., & Duckett, C. S. (2008) · Biochemical Journal · doi:10.1042/bj20081188 · Cited by 22
“One possibility relates to previous studies showing that a lack of c-IAPs can increase production of and sensitivity to TNF [21-23].”
BackgroundHarnessing programmed cell death as a therapeutic strategy in rheumatic diseases
Ramaswamy, M., Deng, M., & Siegel, R. M. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.225 · Cited by 21
Small molecule inhibitor of apoptosis proteins antagonists: a patent review
Hird, A. W., Aquila, B. M., Hennessy, E. J., Vasbinder, M. M., & Yang, B. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1041922 · Cited by 19
IKKβ-mediated nuclear factor-κB activation attenuates smac mimetic–induced apoptosis in cancer cells
Bai, L., Chen, W., Chen, W., Wang, X., Tang, H., & Lin, Y. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0068 · Cited by 19
Yamaguchi, N., Yokota, M., Taguchi, Y., Gohda, J., & Inoue, J. (2012) · Genes to Cells · doi:10.1111/gtc.12012 · Cited by 18
CLDN1 regulates trophoblast apoptosis and proliferation in preeclampsia
Zhang, Y., Qin, X., Mo, H., Qin, S., Qin, S., Zhang, C., Wei, X., Liu, X., Zhang, Y., Tian, F., et al. (2021) · Reproduction · doi:10.1530/rep-20-0677 · Cited by 18
Negi, A., Kesari, K. K., & Voisin‐Chiret, A. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112523 · Cited by 18
Thorne, A. J., Bansal, A., Necker‐Brown, A., Mostafa, M., Gao, A., Georgescu, A., Kooi, C., Leigh, R., & Newton, R. C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0286783 · Cited by 18
Palacios, Y., García‐Laínez, G., Sancho, M., Gortat, A., Orzáez, M., & Pérez‐Payá, E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.255364 · Cited by 18
A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin
Lee, E. K., Jinesh, G. G., Laing, N. M., Choi, W., McConkey, D. J., & Kamat, A. M. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25326 · Cited by 18
Wong, H., Budha, N. R., West, K. A., Blackwood, E. R., Ware, J. A., Yu, R., Darbonne, W. C., Gould, S. E., Steigerwalt, R. W., Erickson, R., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs235 · Cited by 18
Metadata
- Authors
- Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., Flygare, J. A., Fairbrother, W. J., Deshayes, K., Dixit, V. M., & Vucic, D.
- Affiliations
- Genentech (US)
- Corresponding author
- Dixit, Vishva M.
- Vucic, Domagoj
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 131
- Issue
- 4
- Pages
- 669-681
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2064299413
- Cited by
- 1,218
- References
- 51
- Citations by year
- 2026: 28 · 2025: 24 · 2024: 39 · 2023: 45 · 2022: 41 · 2021: 60 · 2020: 59 · 2019: 54 · 2018: 69 · 2017: 64 · 2016: 78 · 2015: 80 · 2014: 100 · 2013: 78 · 2012: 71
- FWCI
- 33.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- inhibitor of apoptosis proteins, IAP antagonists, cIAP1, cIAP2, autoubiquitination, proteasomal degradation, NF-κB signaling, non-canonical NF-κB signaling, NIK, TNF signaling, apoptosis, cancer therapeutics
- MeSH terms
- Animals, Cell Line, Humans, Neoplasms, Tumor Necrosis Factor-alpha, Molecular Structure, Signal Transduction, NF-kappa B, Apoptosis, Protein Structure, Tertiary, Polyubiquitin, Proteasome Endopeptidase Complex, Inhibitor of Apoptosis Proteins, Mice, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review